
51 - 200 employees
🏥 Healthcare
🧬 Biotechnology
💰 $50M Series C on 2022-09
Healthcare • Biotechnology
Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. Our primary mission is to improve neurological care for emergency and ICU patients. Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. The System can be set up by any healthcare provider within minutes. Now with Clarity, Ceribell offers 24/7 continuous bedside EEG monitoring and alert.
Selected: 🆕 Date Added.
🕒 September 24
Health systems sales leader expanding Ceribell’s point-of-care EEG platform across U.S. hospitals. Building IDN partnerships, negotiating enterprise agreements, and driving clinical and economic adoption.
🇺🇸 United States – Remote
💵 $185k - $325k / year
💰 $50M Series C on 2022-09
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Manager
👻 Ghost score 10%
🕒 September 4
Medical Director advancing Ceribell’s point-of-care EEG technology for critical care. Leading clinical strategy, physician engagement, evidence generation, and commercialization.
🇺🇸 United States – Remote
💵 $300k - $309k / year
💰 $50M Series C on 2022-09
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 6%
🕒 July 14
Senior Manager overseeing AI Engineering projects for Ceribell, a medical technology company. Transforming diagnosis and management of neurological conditions through innovative AI solutions.
🇺🇸 United States – Remote
💵 $177k - $226k / year
💰 $50M Series C on 2022-09
⏰ Full Time
🟠 Senior
🤖 AI Engineer
👻 Ghost score 27%